
KALA
USDKALA BIO Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$0.740
Максимум
$0.800
Минимум
$0.740
Объем
0.08M
Фундаментальные показатели компании
Рыночная капитализация
5.3M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.11M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for
Связанные акции
HGV
Hilton Grand Vacations Inc.
AIT
Applied Industrial Technologies Inc.
RAMP
LiveRamp Holdings Inc.
GLP
Global Partners LP Common Units representing Limited Partner Interests
BCO
Brinks Company (The)
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.